Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point

Size: px
Start display at page:

Download "Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point"

Transcription

1 National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: A panel data analysis Clive Richardson Panteion University of Social & Political Sciences, Athens & Greek Reitox Focal Point

2 Author list of submitted paper G. Nikolopoulos, A. Fotiou, E. Kanavou, C. Richardson, M. Detsis, A. Pharris, J.E. Suk, J.C. Semenza, C. Costa-Storti, D. Paraskevis, M.-M. Malliori, S.R. Friedman, A. Hatzakis Athens University / Greek Focal Point / ECDC / EMCDDA / NDRI

3 Introduction Economic downturn started in Some European countries have been hit severely by the crisis (e.g. Greece) Interest in the impact of financial crisis on health (Stuckler, 2011). including communicable diseases (Bonovas & Nikolopoulos, J Prev Med Hyg 2012; Suhrcke, PLoS One 2011)

4 Big events (such as wars, crises, transitions) have unleashed HIV epidemics in the past (e.g. Russia in the 1990s) (Friedman, Int J Drug Policy 2009) Stable or declining trends in HIV cases among drug injectors in Europe (ECDC/WHO. HIV/AIDS Surveillance in Europe 2012) but large increases in Greece and Romania (Paraskevis, Euro Surveill 2011; Pharris, Euro Surveill 2011)

5 Annual new HIV diagnoses in PWID

6 Annual new HIV diagnoses in PWID Greece Romania Bulgaria

7 Objective To explore the relationship between economic recession, socio-economic, policy and structural indicators, and increases in reported HIV infections among people who inject drugs (PWID) in the European Economic Area (EU, Iceland, Norway)

8 Data sources ECDC (TESSy) Eurostat EMCDDA

9 Methods

10 Dependent variable Newly diagnosed HIV cases among PWID Dichotomized = 1 if there was a significant increase in diagnosis rate that year, and for years following = 0 otherwise i.e. indicator of an outbreak

11 Dependent variable Country with an outbreak Country with no outbreak

12 Independent variables macro level GDP pre capita % change in GDP from previous year S80/S20 measure of income inequality Gini index of income inequality Public wealth index = GDP p.c./ (S80/S20) Population at risk of poverty Unemployment

13 Independent variables policy level Government expenditure on health Government expenditure on social protection Recorded drug trafficking crimes Syringes distributed or exchanged OST clients

14 Independent variables drug user level Problem drug users /1000* Problem injecting drug users /1000* New clients entering treatment Opioid treatment entries who inject (%) Cocaine treatment entries who inject (%) Opioid treatment entries who use daily (%) * Too many missing values not used

15 Univariate results (2-year lag; results similar for other lags) Variable OR 95% Conf. Interval GDP growth rate Poverty S80/S Gini index Public wealth index

16 Multivariable results Lag Variable OR 95% Conf. Int. 1 year GDP growth rate Gini index years GDP growth rate Gini index years GDP growth rate Gini index

17 Main finding Increased risk of an HIV outbreak among drug injectors in this set of countries is associated with declining rate of GDP growth the unequal distribution of national income

18 These results agree with several previous studies: GDP and Gini were associated with TB mortality rates in Latin America (Biggs, Soc Sci Med 2010) Gini was associated with HIV prevalence in 90 countries (Holmqvist 2009 working paper) Gini was associated with HIV prevalence in African countries (Tsafack-Temah 2008 PhD thesis)

19 Gini was correlated with HIV prevalence in 77 large US metropolitan areas among PWID.. and with AIDS mortality rates in heterosexuals in US metropolitan areas (Friedman, Ann Epidemiol 2014) Homelessness in drug injectors was associated with both GDP and HIV prevalence in Athens (Sypsa, Am J Public Health 2014; Paraskevis, PLoS One 2013)

20 Limitations Ecological correlations Unable to study pathways from large-scale processes to HIV risk Lack of HIV incidence estimates in PWID HIV prevalence estimates in PWID available at regional level only Limited availability of data on other key determinants of HIV risk in PWID

21 Recommendations Despite their inherent limitations, analyses of this kind could inform policy makers Maintaining equality could help avert HIV epidemics in PWID while GDP is falling Need to study the pathways from Big Events to HIV risk

22 Acknowledgments The study was funded by the European Centre for Disease Prevention and Control, ECDC grant ECD.4167 Georgios Nikolopoulos was supported by the IAS/NIDA fellowship during the conduct of this analysis

23 Clive Richardson Anastasios Fotiou

Drug situation in Greece

Drug situation in Greece 16/6/217 INDICATIONS FOR DECLINE IN HCV AND HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS IN ATHENS, GREECE Anastasios Fotiou Greek Reitox focal point at the Athens University Mental Health Research Institute

More information

The impact of economic recession on drug users and drug treatment

The impact of economic recession on drug users and drug treatment The impact of economic recession on drug users and drug treatment Designing and implementing responsive drug policies under fiscal constraints: the case of Greece Meni Malliori Assoc. Prof. of Psychiatry

More information

Most recent data, analyses and feed-back from the 2016 DRID national updates

Most recent data, analyses and feed-back from the 2016 DRID national updates Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID

More information

Recent trends in drug problems and service provision in Greece

Recent trends in drug problems and service provision in Greece Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug

More information

ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC update to the EU Commission Think Tank on HIV/AIDS ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think

More information

Economic Recession and Health: the Case of Greece

Economic Recession and Health: the Case of Greece Economic Recession and Health: the Case of Greece Dr. Filippos Filippidis School of Public Health Imperial College London 1 Outline Background Economic recession in Greece Economic recession and health

More information

The epidemiology of HIV infection in Greece HIV/AIDS reporting system

The epidemiology of HIV infection in Greece HIV/AIDS reporting system HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention

More information

HIV transmission in the migrant population. D. Paraskevis

HIV transmission in the migrant population. D. Paraskevis HIV transmission in the migrant population D. Paraskevis Content Definitions Epidemiology of HIV in migrants Methods to estimate the origin of HIV acquisition Molecular epidemiology Bayes method based

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

HEPATITIS C ELIMINATION IN GREECE

HEPATITIS C ELIMINATION IN GREECE HEPATITIS C ELIMINATION IN GREECE ANGELOS HATZAKIS Professor of Epidemiology & Preventive Medicine Athens University Medical School Co-Chair, Hepatitis B & C Public Policy Association London, UK June 5,

More information

TB control. Assumptions. Reality. Symptomatic patients seek care. Patients and professionals don t recognise symptoms

TB control. Assumptions. Reality. Symptomatic patients seek care. Patients and professionals don t recognise symptoms Dr Al Story TB control Assumptions Symptomatic patients seek care Patients self administer treatment Active Case Finding (ACF) is too resource intensive Patients are hard-to-reach Reality Patients and

More information

HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data -

HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data - HIV outbreaks among PWID in Europe linking economic, epidemiological and service provision data - EMCDDA annual expert meeting on drug-related deaths and drug-related infectious diseases 18/10 /2013 -

More information

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term

More information

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece IVHEM, 6-7 December 2018 ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece Vana Sypsa Department of Hygiene, Epidemiology and Medical Statistics Medical School,

More information

ECDC s role in the fight against HIV/AIDS in Europe

ECDC s role in the fight against HIV/AIDS in Europe European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November

More information

A methodology for an EU cross-country comparison?

A methodology for an EU cross-country comparison? A methodology for an EU cross-country comparison? Public expenditure for drug treatment in hospitals dr. & prof. dr. Freya Vander Laenen Freya.Vanderlaenen@UGent.be Background 2 COMPARATIVE DRUG POLICY

More information

MEETING REPORT. 1 Introduction and objectives

MEETING REPORT. 1 Introduction and objectives MEETING REPORT Detecting and responding to outbreaks of HIV among people who inject drugs: best practices in HIV prevention and control Tallinn, 29 30 March 2012 1 Introduction and objectives A risk assessment

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic

More information

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Reflecting on ten years of progress in the fight against AIDS, TB and malaria Reflecting on ten years of progress in the fight against AIDS, TB and malaria Michel Kazatchkine UN Secretary General s Special Envoy on HIV/AIDS in Eastern Europe and central Asia Ten years of progress:

More information

The WHO global TB database

The WHO global TB database ANNEX 1 The WHO global TB database GLOBAL TUBERCULOSIS REPORT 2017 149 A patient with MDR-TB in Dushanbe, Tajikistan WENDY MARIJNISSEN / MSF A.1 Database contents The 2017 global TB report is based on

More information

Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014

Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Epidemiology of tuberculosis in Europe Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Tuberculosis surveillance in the EU Aim: To provide a complete

More information

Social determinants of infectious diseases

Social determinants of infectious diseases Social determinants of infectious diseases Informal Health Council, 5-6 July 2011, Sopot, Poland President, Commissioner, Ministers, thank you for asking me to contribute to your debate. Over the next

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

Economic crisis and communicable diseases in Greece

Economic crisis and communicable diseases in Greece Economic crisis and communicable diseases in Greece XIX Taller Internacional sobre TB Unidad de Investigaciónen Tuberculosis de Barcelona Barcelona, 23-24/11/2015 Takis Panagiotopoulos Professor Dept of

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Riga Dr Al Story

Riga Dr Al Story Riga 2013 Dr Al Story Plan TB control - Flawed assumptions 21 st century challenges People not Pathogens Intensified case finding - next steps Protect the public Treat the patient Infection & Inequality

More information

People not Pathogens. Al Story

People not Pathogens. Al Story People not Pathogens Al Story Plan Changing epidemiology ACF - Case management - Missed opportunities Epi transition Exposure and infection Overcrowding Homelessness Incarceration Health care access Progression

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

Annual report 2009: the state of the drugs problem in Europe

Annual report 2009: the state of the drugs problem in Europe Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100

More information

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS Holly Hagan, PhD Professor Co-Director, Center for Drug Use and HIV Research Principal Investigator, HCV Synthesis Project New York University HCV prevalence

More information

2nd meeting on detecting and responding to outbreaks of HIV among people who inject drugs

2nd meeting on detecting and responding to outbreaks of HIV among people who inject drugs Final Draft MEETING REPORT 2nd meeting on detecting and responding to outbreaks of HIV among people who inject drugs 12 October 2012, EMCDDA, Lisbon, Portugal 1. Introduction and objectives A risk assessment

More information

Drug-related infectious diseases

Drug-related infectious diseases Drug-related infectious diseases Mike Catchpole Chief Scientist, European Centre for Disease Prevention and Control Tuesday 24th October 2017 Basic (Case) Reproduction Rate All you need to know to design

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases

More information

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

Drug Consumption Rooms Worldwide

Drug Consumption Rooms Worldwide Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR

More information

EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS

EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS Cinthia Menel Lemos cinthia.menel-lemos@ec.europa.eu Project Officer Executive Agency for Health

More information

NAD. Greek crisis: Impact on drug treatment services, research and population. Commentary

NAD. Greek crisis: Impact on drug treatment services, research and population. Commentary NAD Commentary Greek crisis: Impact on drug treatment services, research and population ANNA TSIBOUKLI Whether the effects of the Greek socio-economic crisis can be portrayed as a humanitarian crisis is

More information

Annual report 2012: the state of the drugs problem in Europe

Annual report 2012: the state of the drugs problem in Europe Annual report 2012: the state of the drugs problem in Europe Ilze Jekabsone, MD, MPH Reitox and international cooperation unit 14 December 2012 2 Setting the scene After 30+ years with heroin centre stage

More information

Review on HIV & Associated Infections in Latvia

Review on HIV & Associated Infections in Latvia Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of

More information

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Syphilis Key facts In 2015, 28 701 syphilis cases were reported in 29 EU/EEA Member States (data were not available from Austria and Liechtenstein),

More information

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Current levels and recent trends in health inequalities in the EU: Updates from the EU Report Anne Scott London Health Observatory Expert Working Group on Social Determinants and Health Inequalities Luxembourg,

More information

Plan. A bit about TB What I do What I should do

Plan. A bit about TB What I do What I should do B R E A K F A S T Plan A bit about TB What I do What I should do 575,475 583,350 810,120 667,228 755,605 7,753,555 1,068,532 2,199,500 3,442,675 1,698,957 3,255,944 2,724,347 745,514 121 39 58 113 3,440

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT. SPECIAL REPORT Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report Summary www.ecdc.europa.eu ECDC SPECIAL REPORT Implementing the Dublin

More information

HIV/AIDS, STI, hepatitis

HIV/AIDS, STI, hepatitis ECDC update HIV/AIDS, STI, hepatitis HIV EU Think Tank meeting Brussels, 25-26 March 2009 European Centre for Disease Prevention and Control HIV and AIDS surveillance activities Coordination of European-wide

More information

Economic crisis, health and

Economic crisis, health and Economic crisis, health and health systems Marina Karanikolos response in Greece Reseach Fellow ECOHOST, LSHTM Health System in Greece Health System Review (2010) precrisis NHS (ESY) coexists with SHI

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations DP/FPA/CPD/BRA/5 Executive Board of the United Nations Development Programme, the United Nations Population Fund the United Nations Office for Project Services Distr.: General 26 September

More information

Illustrating HIV/AIDS in the United States Update

Illustrating HIV/AIDS in the United States Update Illustrating HIV/AIDS in the United States 2016 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S. alongside critical

More information

World Drug Report 2017

World Drug Report 2017 World Drug Report 2017 DEMAND Global trends in estimated number of drug users and people with drug user disorders, 2006-2015 Global trends in the estimated prevalence of drug use and prevalence of people

More information

Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH

Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH Lessons from the European Health Report: implications for sustainable societies Dr Claudia Stein MD, PhD, FFPH Director Division of Information, Evidence, Research and Innovation WHO Regional Office for

More information

The Syndemics of HIV, Hepatitis, and Overdose

The Syndemics of HIV, Hepatitis, and Overdose The Syndemics of HIV, Hepatitis, and Overdose Sara Zeigler Associate Director for Policy Office of Policy, Planning and Partnerships (proposed) Centers for Disease Control and Prevention National Center

More information

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA DOCTORAL THESIS ABSTRACT Epidemiological aspects of tuberculosis disease in disadvantaged population groups in Dolj county in the period 2006-2011 PhD Supervisor,

More information

The Economics of the Global Response to HIV/AIDS

The Economics of the Global Response to HIV/AIDS The Economics of the Global Response to HIV/AIDS Markus Haacker Harvard School of Public Health Center for Global Development, Washington DC, June 29, 2016. 1 Today s discussion focuses on two sets of

More information

Nigerian Epidemiological Network on Drug Use (NENDU)

Nigerian Epidemiological Network on Drug Use (NENDU) This project is funded by the European Union - 1 - Nigerian Epidemiological Network on Drug Use (NENDU) Experience of piloting drug information systems in Nigeria Global Drug early Warning System (GDEWS)

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE

AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE Psihijat.dan./2016 /48/2 / 155-160/ 155 Opšti rad UDK 613.86(495) COBISS.SR-ID 237509644 AUSTERITY, ECONOMIC CRISIS, AND THEIR PERSISTENT EFFECTS ON MENTAL HEALTH IN GREECE Nikos Christodoulou 1, George

More information

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21,

Cost of Disorders of the Brain in Europe Gustavsson et al. Cost of disorders of the brain in Europe Eur. Neuropsych. (2011) 21, Cost of Disorders of the Brain in Europe 2010 Gustavsson et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsych. (2011) 21, 718-779 Steering Committee Prof Jes Olesen 1 Prof Bengt Jönsson

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

HIV and Paediatrics in Central Europe

HIV and Paediatrics in Central Europe 2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in

More information

Unmet Oral Health Needs of Persons Living With HIV/AIDS in the United States

Unmet Oral Health Needs of Persons Living With HIV/AIDS in the United States Unmet Oral Health Needs of Persons Living With HIV/AIDS in the United States What Can We Do To Improve Services? Nicholas G. Mosca, DDS, DrPH CrescentCare Health/NO AIDS Task Force April 25, 2017 National

More information

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017 ICTMM 21 Sept 2016 Mark Boyd Chair of Medicine/Professorial Fellow University of Adelaide/UNSW University of Adelaide 2 1 University of Adelaide 3 Myanmar BASIC SOCIO-DEMOGRAPHIC INDICATORS Total population

More information

Perspective.

Perspective. Perspective Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization s global health sector strategy core indicators and

More information

Public drug policies Catalonia

Public drug policies Catalonia Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia

More information

(Please check against delivery) EMBARGOED FOR 20 APRIL 2017 AT 0900 EST/1500 CET. Ladies and gentlemen,

(Please check against delivery) EMBARGOED FOR 20 APRIL 2017 AT 0900 EST/1500 CET. Ladies and gentlemen, The European Stability Mechanism - A firewall for the eurozone and first line of defense for global financial stability Klaus Regling, ESM Managing Director Washington DC, 20 April 2017 (Please check against

More information

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA

Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant

More information

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Dagmar Hedrich & Isabelle Giraudon, EMCDDA Bergen, 1 September 2015 OVERDOSEKONFERANSEN 2015 ThINCBergen2015: The

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

Epidemiological trends of TB in Eastern Europe TB and migration

Epidemiological trends of TB in Eastern Europe TB and migration KOCH-METSCHNIKOW-FORUM МEЧНИКОВ-КОХ-ФОРУМ XX Congreso Internacional sobre Tuberculosis UITB-216 November 21 and 22, 216 Epidemiological trends of TB in Eastern Europe TB and migration Timo Ulrichs Koch-Metschnikow-Forum,

More information

Health and well-being a perspective from WHO

Health and well-being a perspective from WHO Meeting of Chief Medical Officers and Chief Nursing Officers Health and well-being a perspective from WHO Zsuzsanna Jakab WHO Regional Director for Europe Health 2020 European policy framework Health 2020

More information

COSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them.

COSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them. COSTA RICA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people

More information

HIV and Tuberculosis in Eastern Europe

HIV and Tuberculosis in Eastern Europe HIV and Tuberculosis in Eastern Europe Daria N. Podlekareva Meeting Standard of Care for HIV and Coinfections in Europe Rome, November 25-16 2014 TB notification rates (per 100.000) European region 2012

More information

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area

Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)

More information

Latest Funding Trends in AIDS Response

Latest Funding Trends in AIDS Response Latest Funding Trends in AIDS Response 20 th International AIDS Conference Melbourne, Australia J.V.R. Prasada Rao United Nations Secretary-General s Special Envoy for AIDS in Asia and the Pacific 21 July

More information

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy

HIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati

More information

Emerging epidemics: Will they derail progress? Eastern/Central Europe

Emerging epidemics: Will they derail progress? Eastern/Central Europe Emerging epidemics: Will they derail progress? Eastern/Central Europe Marieta Simonova, MD Clinic of Gastroenterology, Military Medical Academy Sofia, Bulgaria Disclosures Speaker/Adviser for AbbVie, Gilead,

More information

Socioeconomic Crisis and its impact on Mental Health in Greece. Stelios Stylianidis Prof. of Social Psychiatry, Panteion University of Athens

Socioeconomic Crisis and its impact on Mental Health in Greece. Stelios Stylianidis Prof. of Social Psychiatry, Panteion University of Athens Socioeconomic Crisis and its impact on Mental Health in Greece Stelios Stylianidis Prof. of Social Psychiatry, Panteion University of Athens The international recession along with local unrelenting spending

More information

NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK

NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK KEY HIV STATISTICS IRAQ 585 HIV cases reported (June 2010) 288 Iraqis (49%) 297 Foreigners (51%) 83% male KEY HIV STATISTICS IRAQ Mode of transmission(n=585)

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 6 December /02 CORDROGUE 103

COUNCIL OF THE EUROPEAN UNION. Brussels, 6 December /02 CORDROGUE 103 COUNCIL OF THE EUROPEAN UNION Brussels, 6 December 2002 15349/02 CORDROGUE 103 NOTE From : Presidency To : European Council No. prev. doc. : 12451/3/02 CORDROGUE 80 REV 3 Subject : Note from the Council

More information

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan HARM REDUCTION WORKS FUND IT! National Report Summary Arguments for strategic investment With the support of The present document contains a summary of the key conclusions and recommendations provided

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 Cristiana Oprea MD, Ph.D Associate Professor Carol Davila University of Medicine and Pharmacy Victor Babes Clinical Hospital for Infectious

More information

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2016 Shigellosis Key facts Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016,

More information

Future infectious disease health threats faced by the EU and the implications for laboratory capacity

Future infectious disease health threats faced by the EU and the implications for laboratory capacity Future infectious disease health threats faced by the EU and the implications for laboratory capacity Mike Catchpole, Chief Scientist European Centre for Disease Prevention and Control Determinants of

More information

Hepatitis C in Massachusetts Epidemiology and Public Health Response

Hepatitis C in Massachusetts Epidemiology and Public Health Response Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Epidemiology and Public Health Response Shauna Onofrey, MPH, Viral Hepatitis

More information

Use of international databases national perspective. Mika Gissler National Institute for Health and Welfare, Finland Karolinska Institutet, Sweden

Use of international databases national perspective. Mika Gissler National Institute for Health and Welfare, Finland Karolinska Institutet, Sweden Use of international databases national perspective Mika Gissler National Institute for Health and Welfare, Finland Karolinska Institutet, Sweden In the beginning There were many actors with quite a little

More information

The impact of economic crisis on suicide in Asia and other regions.

The impact of economic crisis on suicide in Asia and other regions. The impact of economic crisis on suicide in Asia and other regions. David Gunnell Bristol Acknowledgements Shu-Sen Chang Nicos Middleton Jonathan Sterne Esben Agerbo Camilla Haw Andrew Cheng Robert Lu

More information

Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States

Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States Show Me the Money: A Discussion about Investments Needed to Change STD Rates in the United States Harrell Chesson Health Economist Centers for Disease Control and Prevention National Coalition of STD Directors

More information

EMCDDA trend report for the evaluation of the EU drugs strategy

EMCDDA trend report for the evaluation of the EU drugs strategy EMCDDA trend report for the evaluation of the 2005 12 EU drugs strategy Contents Executive summary...4 Drug use and drug-related problems...4 Drug supply and new drugs...6 Drug policies...7 Demand reduction...8

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION DEVELOPMENT The European Union confronts HIV/AIDS, malaria and tuberculosis A comprehensive strategy for the new millennium EUROPEAN COMMISSION DE 121 FEB 2004 A global challenge Every minute, 11 people

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

What happened? GDP per capita (2007=1) What happened to health? The health effects of a financial crisis: epidemiology on a large scale

What happened? GDP per capita (2007=1) What happened to health? The health effects of a financial crisis: epidemiology on a large scale The health effects of a financial crisis: epidemiology on a large scale Martin McKee Hong Kong, August 216 Twitter: @martinmckee What happened? GDP per capita (27=1) 1.1 1.5 1..95.9.85.8.75 Germany United

More information

HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00

HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00 HCV Elimination Mini Policy Summit Eliminating HCV in Greece Hosted by MEP Georgios Kyrtsos European Parliament, 22 November 2017, A5E-3, 10:00 12:00 Speakers biographies In order of appearance Georgios

More information

Monitoring hepatitis C virus infection treatment uptake among people who inject drugs in Europe

Monitoring hepatitis C virus infection treatment uptake among people who inject drugs in Europe Monitoring hepatitis C virus infection treatment uptake among people who inject drugs in Europe Draft report 11 th May 2012 TG Meeting participants 1. Introduction 3 2. HCV treatment meeting summary 3

More information

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016 REPORT Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016 July 2017 Prepared by: Jen Kates & Adam Wexler Kaiser Family Foundation and Eric Lief Consultant and UNAIDS Donor government

More information